dpp4 glp 1 combination Dipeptidyl peptidase-4 inhibitor GLP-1 Agonists: Increasing Effective Insulin

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

This guide explores the clinical evidence, biomarker considerations, and how providers evaluate safety when considering GLP-1 therapy for patients with inflammatory bowel disease

Discover the effects of withdrawing from weight loss drugs and explore the best GLP1 options for weight loss at Atlantic Gastroenterology

Introduction: Obesity is a global epidemic affecting 2.5 billion people and is recognized as the fourth leading cause of global mortality

Are GLP-1 meds like Ozempic affecting your PRP therapy results